The RELIEFSEQ® testing line will

CHANGE THE LIVES

OF PATIENTS IN NEED. 

We offer a line of diagnostic tests using  proprietary NextGen Sequencing technology to screen complex chronic respiratory diseases and provide Precision Medicine for the patient. With our ReliefSeq® line of assays, we profile conditions in days that normally take months or years to accurately diagnose.

The technology was designed specifically for high sensitivity detection of offending pathogens in tandem with immune status markers using our ImmuneLink™ technology. Insights are generated using our ReliefSeq® Data Engine with specifically designed algorithms and models targeting this patient class to provide physicians with a disease specific profile from a single test.

Our AsthmaID® and Respiratory ID® tests provides physicians a comprehensive picture in asthma and other chronic respiratory conditions to better guide treatment and monitor effectiveness to improve the quality of life for patients suffering from severe and uncontrolled symptoms.

AsthmaID® delivers a focused profile of the disease status of the individual patient thereby guiding treatment options to shift the entire course of the disease. There are many drivers of asthma which can be addressed. In a matter of days, elucidate which interventions can help your patient minimize disease severity. Because the disease profile can change over time due to numerous causes, timely monitoring can help provide the best treatment and patient quality of life to manage Asthma.

Respiratory ID® provides both a high-sensitivity test and a broad view of underlying causes of chronic respiratory disease in a matter of days and is not available with current technologies. Our advanced data analysis profiles the underlying disease drivers for the patient which physicians can use in determining a course of treatment. Prior to Respiratory ID®, this information took months and years to acquire with numerous physician visits while patient suffering went unresolved.

PRECISION MEDICINE

We saw a need for patients across multiple diseases that needed a new solution to profile their disease with a high sensitivity and targeted approach. Bringing together relevant pathogen detection and immune activity with our breakthrough ImmuneLink™ and ReliefSeq® Data Engine technology profiles each individual patient at that specific point during the course of care. Using multiple studies and clinical case studies, we believe we have created a powerful solution that supports physicians across multiple disciplines to put an end to the multi-year diagnostic difficulties these patients endure. The result provides physicians the information they need to improve outcomes and enhance the course of care for each individual patient.

OUR SCIENCE

COMING SOON

CLINICAL DATA

We are currently working with select partners to provide our ReliefSeq line of testing. Contact us now to learn more about ordering Asthma ID® and Respiratory ID® for your patients!

CHECK BACK HERE FOR UPDATES